KIORA PHARMACEUTICALS, INC. Deferred Tax Liabilities, Property, Plant and Equipment
KIORA PHARMACEUTICALS, INC. (KPRX) had Deferred Tax Liabilities, Property, Plant and Equipment of $0 as of 2023-12-31, per its 10-K filed 2024-03-25.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities
us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment · last filed 2024-03-25
- 2023-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $0.00.
- 2022-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $477.00.
- 2021-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $956.00; Deferred Tax Liabilities, Property, Plant and Equipment as first filed $955.00.
- 2020-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $1.08K.
| Period end | Deferred Tax Liabilities, Property, Plant and Equipment | Deferred Tax Liabilities, Property, Plant and Equipment as first filed |
|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-25 | |
| 2022-12-31 | $477.00 10-K · filed 2024-03-25 | |
| 2021-12-31 | $956.00 10-K · filed 2023-03-23 | $955.00 10-K · filed 2022-04-15 |
| 2020-12-31 | $1.08K 10-K/A · filed 2022-07-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |